oppn parties Shortcuts Will Not Work In Developing A Vaccine For Coronavirus

News Snippets

  • UP Police have arrested three government officials and 9 others for the murder of journalist and RTI activist Raghvendra Bajpai in Sitapur
  • Union minister Jitendra Singh said terrorists were behind the killing of three persons in Marhoon village in Kathua district of J&K
  • Uneasy calm remains in Manipur as tribal areas shut down after the Kuki-Zo Council called for an indefinite shutdown
  • Indian drug manufacturers are set to produce Emplagliflozin at a tenth of the price of the innovator Boehringer Ingelheim, after its patent expires on March 11. The companies in the running are Mankind, Torrent, Alkem, Dr Reddys and Lupin
  • The Budget session of Parliament will resume today against the backdrop of ongoing tussle over delimitation and three-language formula
  • Police have arrested a third suspect in the horrific rape-murder of foreign tourists and their Indian friend in Hampi in Karnataka
  • Stock brokers are upbeat that the present downtrend in the markets will see a reversal in March with reports by international analysts suggesting that the worst in the tariff war between the US and China and other nations almost over.
  • The Centre is in the process of implementing a 23-point agenda for regulation and reforms in areas like land, labour, utilities and permits to make life easier for businesses across the country
  • Finance Minister Nirmala Sitharaman said that if businessmen take one step, the government is ready to take 10 steps with them
  • Rohit Sharma, Shreyas Iyer, K L Rahul shine with the bat after the spinner restrict New Zealand to just 251
  • Unbeaten India lift the ICC Champions Trophy by beating New Zealand by 4 wickets
  • 2nd ODI: Rohit Sharma roars back to form with a scintillating ton as India beat England by 4 wickets in a high scoring match in Cuttack
  • Supreme Court will appoint an observer for the mayoral poll in Chandigarh
  • Government makes it compulsory for plastic carry bag makers to put a QR or barcode with their details on such bags
  • GBS outbreak in Pune leaves 73 ill with 14 on ventilator. GBS is a rare but treatable autoimmune disease
Audacious gun-point robbery at a jewellery showroom in Ara in Bihar /////// Bhojpur Police chase the robbers and arrest two of them after a gunfight /////// Four gang members still at large /////// Jewellery worth Rs 15cr recovered from the total Rs 23cr worth looted, with one bag still missing
oppn parties
Shortcuts Will Not Work In Developing A Vaccine For Coronavirus

By Sunil Garodia
First publised on 2020-07-06 18:09:56

About the Author

Sunil Garodia Editor-in-Chief of indiacommentary.com. Current Affairs analyst and political commentator.

Vaccines are used to prevent infections. Hence, their effectiveness has to be scientifically proven as per admissible norms before they are launched in the market for the use of the general public. However strong and urgent be the health scare for which the vaccine is being developed, the due process cannot be bypassed to launch a product that has not been stringently tested and approved for its efficacy in preventing the infection.

Hence, the ICMR directive to Bharat Biotech to "speed-up" clinical trials of the vaccine, that they are jointly developing as a "top priority project", so that it can be launched within August 15 must be condemned. Clinical trials cannot be sped up. There are thousands of things involved and continuous feedbacks and monitoring of patients administered with the vaccine during such trials take time. In any case, no vaccine or drug can be safely launched before successful clinical trials on a given set of individuals (a small number in Phase 1 and then a much larger number in Phase 2) over a given period of time. The results, such as the development of antibodies in the recipients, are closely monitored by scientists. It is not a process that submits itself to pre-set deadlines. Even the identification, selection and getting volunteers are time consuming processes.

The bureaucracy in India must not try to undermine scientific norms just to please their political masters. In fact, since they are supposed to be subject-experts (as Dr. Balram Bhargava, director-general of ICMR is), they must make the political leadership aware of the pitfalls involved in rushing things. There is no doubt that a vaccine, when developed, would be a huge relief to the entire humanity. But if due process is not followed and a dud vaccine is launched, India will become the laughing stock of the world. Hence, instead of setting deadlines, ICMR should insist on getting things done in the most scientific way following all global norms. Shortcuts will be self-defeating.